Drug search by name

Lapatinib Ditosylate and Dermatologic toxicities

Result of checking the interaction of drug Lapatinib Ditosylate and disease Dermatologic toxicities for safety when used together.

Check result:

Lapatinib Ditosylate <> Dermatologic toxicities

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Cutaneous reactions, in some cases severe, have been reported with the use of EGFR inhibitors. Monitor patients who develop dermatologic or soft tissue toxicities while receiving these agents for the development of inflammatory or infectious sequelae. It is recommended to withhold treatment, and appropriate measures should be instituted as appropriate or discontinue the use of these agents for dermatologic or soft tissue toxicity associated with severe or life-threatening inflammatory or infectious complications. Advise patients to wear sunscreen and hats and limit sun exposure while receiving therapy with these agents as exposure to sunlight can exacerbate dermatologic toxicities.

Lapatinib Ditosylate

Generic Name: lapatinib

Brand Name: Tykerb

Synonyms: Lapatinib

What is Lapatinib Ditosylate?